Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Reduvo approval soon

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Jun 06, 2022 8:54am

226 Views

Post# 34733524

Reduvo approval soon

From Last NR "The Company is in discussions with Health Canada to address final commentary on the submission. REDUVO™ remains a top priority and the Company is ready to launch manufacturing activities as soon as possible following regulatory approval" this sounds very close. Days or weeks imo. $$$ will flow in soon from Reduvo. I think that is why they hired cfo as they are going to revenue generating pharma

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?